Coronary stents release the drug Biolimus A9
Vietnam·Biomatrix Neoflex Drug Eluting Coronary Stent System·Biosensors Interventional Technologies Pte. Ltd.·Registered Mar 31, 2022 – Mar 30, 2024Expired- Analysis ID
- 1389
- Product Type
- Biomatrix Neoflex Drug Eluting Coronary Stent System
- Manufacturer
- Biosensors Interventional Technologies Pte. Ltd.
- Manufacturer Country
- Singapore
- Product Owner
- Biosensors Europe SA
- Owner Country
- Switzerland
- Authorized Representative
- DAN THANH PHARMACEUTICAL TRADING COMPANY LIMITED
- Unit
- Cái
- Registration Date
- Mar 31, 2022
- Expiry Date
- Mar 30, 2024
- Status
- Còn hiệu lực
- Maximum Selling Price
- 46200000 VND
Companies providing products similar to "Coronary stents release the drug Biolimus A9"
Recently registered similar products
Access comprehensive regulatory information for Coronary stents release the drug Biolimus A9 in Vietnam's medical device market through Pure Global AI's free database. is registered under number 1389 and manufactured by Biosensors Interventional Technologies Pte. Ltd.. The authorized representative in Vietnam is DAN THANH PHARMACEUTICAL TRADING COMPANY LIMITED.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Biosensors Interventional Technologies Pte. Ltd., and 2 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.